Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older

Table 3 Exclusion criteria of the SALT Osteoporosis Study

Exclusion criteria
Age ≥ 91 years^a
Actual use of bone sparing drugs^b
Use of bone sparing drugs during the preceding 5 years
Terminal illness
Not being able to participate in the study or no consent
Weight > 135 kg^c
Corticosteroid use of ≥7.5 mg prednison equivalent per day

^aCalculation of FRAX (fracture risk assessment tool) is not possible for this age category
^bBisphosphonates, strontiumranelate, estrogens, selective estrogen receptor modulators, parathyroid hormone analogues or denosumab. If new bone sparing drugs will become available during the trial, they were added to the exclusion list
^cMaximum weight for dual-energy x-ray absorptiometry measurement